Skip to main content

Viewpoint: How Boston’s life sciences industry can lead and improve public health

The traditional process of patients accepting whichever medication a doctor recommends is starting to disappear. Patients are also learning more about drugs on their own. Companies can dispel misinformation by becoming information brokers themselves, writes a Boston-based CEO of a New York company.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.